|
Volumn 21, Issue 24, 2013, Pages 7830-7840
|
Design and synthesis of novel antimicrobials with activity against Gram-positive bacteria and mycobacterial species, including M. tuberculosis
|
Author keywords
Acrylic esters; Anti tuberculosis; Michael acceptor; Mycobacterium smegmatis; Mycobacterium tuberculosis
|
Indexed keywords
1,2 ETHYL 2 [4 (TERTBUTYL)BENZOYL]CYCLOPROPANECARBOXYLATE;
2,3 ETHYL 3 [4 (TERTBUTYL)BENZOYL]OXIRANE 2 CARBOXYLATE;
3 (4 TERT BUTYL PHENYLSULFANYL) PROPIONIC ACID ETHYL ESTER;
3 (BENZO[D]THIAZOL 2 YLTHIO) N,N DIISOPROPYLACRYLAMIDE;
3 (BENZO[D]THIAZOL 2 YLTHIO)ACRYLIC ACID;
3 [[4 (TERT BUTYL)PHENYL]THIO] N CYCLOPROPYLACRYLAMIDE;
3 [[4 (TERT BUTYL)PHENYL]THIO] N METHYL N PHENYLACRYLAMIDE;
3 [[4 (TERT BUTYL)PHENYL]THIO] N METHYLACRYLAMIDE;
3 [[4 (TERT BUTYL)PHENYL]THIO] N PHENYLACRYLAMIDE;
3 [[4 (TERT BUTYL)PHENYL]THIO] N,N DIISOPROPYLACRYLAMIDE;
3 [[4 (TERT BUTYL)PHENYL]THIO] N,N DIMETHYLACRYLAMIDE;
3 [[4 (TERT BUTYL)PHENYL]THIO]ACRYLIC ACID;
3 METHYLBUT 2 EN 1 YL 4 [4 (TERT BUTYL)PHENYL] 4 OXOBUT 2 ENOATE;
4 [4 (TERT BUTYL)PHENYL] 4 OXOBUT 2 ENOIC ACID;
ANTIINFECTIVE AGENT;
CYCLOPROPYLMETHYL 3 [[4 (TERT BUTYL)PHENYL]THIO]ACRYLATE;
ETHAMBUTOL;
ETHYL 2 [4 (TERT BUTYL)BENZOYL]BENZOATE;
ETHYL 4 (BENZO[B]THIOPHEN 2 YL) 4 OXOBUT 2 ENOATE;
ETHYL 4 4 (BENZO[B]THIOPHEN 2 YL) 4 HYDROXYBUT 2 YNOATE;
ETHYL 4 [4 (TERT BUTYL)PHENYL] 4 HYDROXYBUT 2 YNOATE;
ETHYL 4 [4 (TERT BUTYL)PHENYL] 4 OXOBUT 2 YNOATE;
ETHYL 4 [4 (TERT BUTYL)PHENYL] 4 OXOBUTANOATE;
ETHYL 4 [4 (TERT BUTYL)PHENYL]BUT 2 ENOATE;
ETHYL 4 [4 (TERT BUTYL)PHENYL]BUTANOATE;
ISONIAZID;
RIFAMPICIN;
TETRACYCLINE;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACILLUS CEREUS;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ESCHERICHIA COLI;
GRAM POSITIVE BACTERIUM;
IN VITRO STUDY;
MICHAEL ADDITION;
MINIMUM INHIBITORY CONCENTRATION;
MYCOBACTERIUM;
MYCOBACTERIUM AVIUM;
MYCOBACTERIUM CHELONEI;
MYCOBACTERIUM FORTUITUM;
MYCOBACTERIUM INTRACELLULARE;
MYCOBACTERIUM KANSASII;
MYCOBACTERIUM SMEGMATIS;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PROTON NUCLEAR MAGNETIC RESONANCE;
STAPHYLOCOCCUS AUREUS;
STEREOSPECIFICITY;
STRUCTURE ACTIVITY RELATION;
X RAY CRYSTALLOGRAPHY;
BACTERIA (MICROORGANISMS);
MYCOBACTERIUM;
MYCOBACTERIUM SMEGMATIS;
MYCOBACTERIUM TUBERCULOSIS;
POSIBACTERIA;
ACRYLIC ESTERS;
ANTI-TUBERCULOSIS;
MICHAEL-ACCEPTOR;
MYCOBACTERIUM SMEGMATIS;
MYCOBACTERIUM TUBERCULOSIS;
ANTI-BACTERIAL AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DESIGN;
GRAM-POSITIVE BACTERIA;
MICROBIAL SENSITIVITY TESTS;
MOLECULAR STRUCTURE;
MYCOBACTERIUM TUBERCULOSIS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84888435178
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2013.10.011 Document Type: Article |
Times cited : (12)
|
References (55)
|